Dilated cardiomyopathy-mediated heart failure induces a unique skeletal muscle myopathy with inflammation.


Journal

Skeletal muscle
ISSN: 2044-5040
Titre abrégé: Skelet Muscle
Pays: England
ID NLM: 101561193

Informations de publication

Date de publication:
24 01 2019
Historique:
received: 09 10 2018
accepted: 10 01 2019
entrez: 26 1 2019
pubmed: 27 1 2019
medline: 2 7 2019
Statut: epublish

Résumé

Skeletal muscle myopathy and exercise intolerance are diagnostic hallmarks of heart failure (HF). However, the molecular adaptations of skeletal muscles during dilated cardiomyopathy (DCM)-mediated HF are not completely understood. Skeletal muscle structure and function were compared in wild-type (WT) and cardiac myosin binding protein-C null mice (t/t), which develop DCM-induced HF. Cardiac function was examined by echocardiography. Exercise tolerance was measured using a graded maximum treadmill running test. Hindlimb muscle function was assessed in vivo from measurements of plantar flexor strength. Inflammatory status was evaluated from the expression of inflammatory markers and the presence of specific immune cell types in gastrocnemius muscles. Muscle regenerative capacityat days 3, 7, and 14 after eccentric contraction-induced injury was determined from the number of phenotypically new and adult fibers in the gastrocnemius, and functional recovery of plantar flexion torque. t/t mice developed DCM-induced HF in association with profound exercise intolerance, consistent with previous reports. Compared to WT, t/t mouse hearts show significant hypertrophy of the atria and ventricles and reduced fractional shortening, both systolic and diastolic. In parallel, the skeletal muscles of t/t mice exhibit weakness and myopathy. Compared to WT, plantar flexor muscles of t/t null mice produce less peak isometric plantar torque (Po), develop torque more slowly (+ dF/dt), and relax more slowly (- dF/dt, longer half-relaxation times,1/2RT). Gastrocnemius muscles of t/t mice have a greater number of fibers with smaller diameters and central nuclei. Oxidative fibers, both type I and type IIa, show significantly smaller cross-sectional areas and more central nuclei. These fiber phenotypes suggest ongoing repair and regeneration under homeostatic conditions. In addition, the ability of muscles to recover and regenerate after acute injury is impaired in t/t mice. Our studies concluded that DCM-induced HF induces a unique skeletal myopathy characterized by decreased muscle strength, atrophy of oxidative fiber types, ongoing inflammation and damage under homeostasis, and impaired regeneration after acute muscle injury. Furthermore, this unique myopathy in DCM-induced HF likely contributes to and exacerbates exercise intolerance. Therefore, efforts to develop therapeutic interventions to treat skeletal myopathy during DCM-induced HF should be considered.

Sections du résumé

BACKGROUND
Skeletal muscle myopathy and exercise intolerance are diagnostic hallmarks of heart failure (HF). However, the molecular adaptations of skeletal muscles during dilated cardiomyopathy (DCM)-mediated HF are not completely understood.
METHODS
Skeletal muscle structure and function were compared in wild-type (WT) and cardiac myosin binding protein-C null mice (t/t), which develop DCM-induced HF. Cardiac function was examined by echocardiography. Exercise tolerance was measured using a graded maximum treadmill running test. Hindlimb muscle function was assessed in vivo from measurements of plantar flexor strength. Inflammatory status was evaluated from the expression of inflammatory markers and the presence of specific immune cell types in gastrocnemius muscles. Muscle regenerative capacityat days 3, 7, and 14 after eccentric contraction-induced injury was determined from the number of phenotypically new and adult fibers in the gastrocnemius, and functional recovery of plantar flexion torque.
RESULTS
t/t mice developed DCM-induced HF in association with profound exercise intolerance, consistent with previous reports. Compared to WT, t/t mouse hearts show significant hypertrophy of the atria and ventricles and reduced fractional shortening, both systolic and diastolic. In parallel, the skeletal muscles of t/t mice exhibit weakness and myopathy. Compared to WT, plantar flexor muscles of t/t null mice produce less peak isometric plantar torque (Po), develop torque more slowly (+ dF/dt), and relax more slowly (- dF/dt, longer half-relaxation times,1/2RT). Gastrocnemius muscles of t/t mice have a greater number of fibers with smaller diameters and central nuclei. Oxidative fibers, both type I and type IIa, show significantly smaller cross-sectional areas and more central nuclei. These fiber phenotypes suggest ongoing repair and regeneration under homeostatic conditions. In addition, the ability of muscles to recover and regenerate after acute injury is impaired in t/t mice.
CONCLUSIONS
Our studies concluded that DCM-induced HF induces a unique skeletal myopathy characterized by decreased muscle strength, atrophy of oxidative fiber types, ongoing inflammation and damage under homeostasis, and impaired regeneration after acute muscle injury. Furthermore, this unique myopathy in DCM-induced HF likely contributes to and exacerbates exercise intolerance. Therefore, efforts to develop therapeutic interventions to treat skeletal myopathy during DCM-induced HF should be considered.

Identifiants

pubmed: 30678732
doi: 10.1186/s13395-019-0189-y
pii: 10.1186/s13395-019-0189-y
pmc: PMC6345027
doi:

Substances chimiques

Inflammation Mediators 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4

Subventions

Organisme : NHLBI NIH HHS
ID : RO1/R56 HL139680
Pays : United States
Organisme : NIH HHS
ID : RO1AM063710
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL130356
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL105826
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR067279
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR068286
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR063710
Pays : United States

Références

J Clin Invest. 1991 Dec;88(6):2077-82
pubmed: 1752965
Circ Res. 2017 Sep 15;121(7):749-770
pubmed: 28912181
Neuromuscul Disord. 2004 Apr;14(4):265-73
pubmed: 15019705
Circulation. 2010 Jan 26;121(3):419-25
pubmed: 20065166
Am J Physiol Heart Circ Physiol. 2014 Mar;306(6):H807-15
pubmed: 24464755
J Physiol. 2007 Jan 1;578(Pt 1):327-36
pubmed: 17038433
Circulation. 2001 Apr 24;103(16):2055-9
pubmed: 11319194
Stem Cells. 2013 Feb;31(2):384-96
pubmed: 23169615
Expert Opin Orphan Drugs. 2015;3(8):869-876
pubmed: 27547593
Circulation. 2006 Jul 11;114(2):126-34
pubmed: 16818813
Lancet. 1997 Apr 12;349(9058):1050-3
pubmed: 9107242
FEBS J. 2018 Jun;285(11):1973-1984
pubmed: 29473995
J Appl Physiol (1985). 2005 Dec;99(6):2189-95
pubmed: 16051711
J Appl Physiol (1985). 2008 Apr;104(4):952-7
pubmed: 18202167
Circ Heart Fail. 2009 Nov;2(6):700-6
pubmed: 19919996
Eur J Cell Biol. 1997 Dec;74(4):391-8
pubmed: 9438136
J Physiol. 2013 Jan 15;591(2):559-70
pubmed: 23109110
Lancet. 2017 Jul 22;390(10092):400-414
pubmed: 28190577
Exp Physiol. 2014 Apr;99(4):609-15
pubmed: 24293507
J Am Coll Cardiol. 1989 Nov 15;14(6):1464-73
pubmed: 2809005
Am J Physiol Cell Physiol. 2007 May;292(5):C1660-71
pubmed: 17151142
FASEB J. 2002 Oct;16(12):1630-2
pubmed: 12207010
J Clin Invest. 1999 Dec;104(12):1771
pubmed: 10606631
Circulation. 2000 Oct 10;102(15):1847-53
pubmed: 11023942
Nat Med. 2015 Jul;21(7):786-94
pubmed: 26053624
Development. 2010 Aug;137(16):2643-52
pubmed: 20610486
Cell Mol Life Sci. 2015 Jan;72(1):153-64
pubmed: 24947322
Stem Cells. 2008 Apr;26(4):997-1008
pubmed: 18258721
Am J Physiol Cell Physiol. 2005 Nov;289(5):C1179-87
pubmed: 16079187
J Physiol. 2002 Apr 15;540(Pt 2):571-80
pubmed: 11956344
J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):287-96
pubmed: 25081949
Int J Cardiol. 1988 Feb;18(2):187-95
pubmed: 2830194
J Mol Cell Cardiol. 2017 Jan;102:83-93
pubmed: 27955979
Circ Res. 2006 Jun 23;98(12):1514-9
pubmed: 16690878
Exp Neurol. 2016 Mar;277:275-282
pubmed: 26775178
Am J Physiol Cell Physiol. 2004 Dec;287(6):C1605-15
pubmed: 15282190
J Exp Med. 2007 May 14;204(5):1057-69
pubmed: 17485518
Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E392-401
pubmed: 19470832

Auteurs

Taejeong Song (T)

Heart Lung Vascular Institute, Division of Cardiology, University of Cincinnati, Cincinnati, OH, 45267, USA.

Palanikumar Manoharan (P)

Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH, 45267, USA.

Douglas P Millay (DP)

Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, 240 Albert Sabin Way, Cincinnati, OH, 45229, USA.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA.

Sheryl E Koch (SE)

Heart Lung Vascular Institute, Division of Cardiology, University of Cincinnati, Cincinnati, OH, 45267, USA.

Jack Rubinstein (J)

Heart Lung Vascular Institute, Division of Cardiology, University of Cincinnati, Cincinnati, OH, 45267, USA.

Judith A Heiny (JA)

Department of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH, 45267, USA.

Sakthivel Sadayappan (S)

Heart Lung Vascular Institute, Division of Cardiology, University of Cincinnati, Cincinnati, OH, 45267, USA. sadayasl@ucmail.uc.edu.
Department of Internal Medicine, Heart, Lung and Vascular Institute, Division of Cardiovascular Health and Sciences, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH, 45267-0575, USA. sadayasl@ucmail.uc.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH